Report: 221 new diabetes treatments are under development

11/14/2012 | PharmaTimes (U.K.)

A total of 221 new drugs for diabetes and related diseases are awaiting FDA approval or are in clinical studies, according to a report from the Pharmaceutical Research and Manufacturers of America. The treatments include 130 for type 2 diabetes, 32 for type 1 diabetes, 14 for unspecified diabetes and 64 for related conditions, with some medications in multiple categories.

View Full Article in:

PharmaTimes (U.K.)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Compliance & Ethics, US Operations
Bristol-Myers Squibb
Princeton, NJ
Manager, Educational Programs
The Food and Drug Law Institute
Washington, DC, DC
Global Medical Safety Director - Transcatheter Heart Valve
Edwards Lifesciences
Irvine, CA
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
South San Francisco, CA
Compliance Manager/Sr. Compliance Manager- Auditing
Genentech
South San Francisco, CA